Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Randomized, Controlled Trial (J-BOND Study)
mediaposted on 2020-10-13, 15:49 authored by Hitoshi Ishii, Hiroki Nakajima, Nozomu Kamei, Tetsuji Niiya, Toru Hiyoshi, Yuko Hiramori, Shigeyuki Ohtsu, Takashi Noto, Dai Shimono
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.